SYNCROSOME is proud to announce that it has joined the ETAP-Lab group – an offshoot of the preclinical CRO ETAP-Lab. 🚀 This acquisition marks a new stage in the company's development. Since its inception in 2000, SYNCROSOME has established itself as a key player in French preclinical...
Open space, relaxation/catering room, meeting room, laboratory with two separate animal facilities with several conventional accommodation areas for rodents and ferrets in 2 different buildings with its own equipped laundry....
For the end of 2019, join us at the BioFIT event in Marseille, France Syncrosome invites you to visit us at BioFit, December 10th to December 11th 2019, in Marseille, France. Emmanuelle Bettendorf, our Business Developer, and Sandra Robelet our Scientific Manager, would be delighted to meet you their and...
Following a decision taken by the Ministry of Higher Education and Research, Syncrosome has been awarded the authorization of « Crédit Impôt Recherche » in France (Research Credit). This authorization is accorded for the years 2019, 2020 and 2021. The French Ministry thereby recognizes that Syncrosome is a fully...
The 19th Annual Biotech in Europe Forum is recognised as the leading international stage for those interested in investing and partnering in the biotech and life science industry. The #Sachs_BEF19 forum will be held for the sixth time in Basel to be close to the largest biopharma hub in...
Syncrosome at Bio2019 Come and meet Syncrosome at #BIO2019 booth #2109. Syncrosome invites you to visit us at BioConvention, June 3rd to June 7th 2016, in Philadelphia, USA. Emmanuelle Bettendorf, our Account Manager would be delighted to meet you their and discuss your in vivo preclinical projects. We...
We wish you Health, Happiness and Prosperity throughout the New year!! ...
The 6ThDrug Discovery Innovation Programme will feature 2 days of interactive presentations, poster presentation and networking opportunity, in Frankfurt (Germany) from 29 to 30thof October. This conference will offer a complete programme focusing on preclinical animal models, breakthrough technologies : Target engagement Advances in medicinal...
Syncrosome invites you to visit us at 2nd Annual Neuroscience Biopartnering & Investment Forum, March 27th to March 28th, In New-York, USA. The Forum will be focused on Neurodegenerative Diseases with a mix of specialist panels and company presentations. It will be the occasion for Syncrosome to...
The last january, all the Syncrosome laboratory an commercial team participated on a 2-day team building event in the French Alpes. It was an enthusiastic "scientific and sportive" experience for everyone! After different meetings to exchange on topics like: Important scientific and commercial results obtained in 2016, ...
SYNCROSOME is proud to announce that it has joined the ETAP-Lab group – an offshoot of the preclinical CRO ETAP-Lab.